Randomized, Double-Blind, Placebo-Controlled Trial of Soluble Tumor Necrosis Factor Receptor: Enbrel (Etanercept) for the Treatment of Idiopathic Pneumonia Syndrome after Allogeneic Stem Cell Transplantation: Blood and Marrow Transplant Clinical Trials Network Protocol

Idiopathic pneumonia syndrome (IPS) is a diffuse, noninfectious lung injury that occurs acutely after allogeneic hematopoietic cell transplantation (HCT). IPS-related mortality has been historically high (>50%) despite treatment with systemic corticosteroids and supportive care measures. We have...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Yanik, Gregory A., Horowitz, Mary M., Weisdorf, Daniel J., Logan, Brent R., Ho, Vincent T., Soiffer, Robert J., Carter, Shelly L., Wu, Juan, Wingard, John R., Difronzo, Nancy L., Ferrara, James L., Giralt, Sergio, Madtes, David K., Drexler, Rebecca, White, Eric S., Cooke, Kenneth R.
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4128626/
https://ncbi.nlm.nih.gov/pubmed/24607553
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2014.02.026
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados